Antibody humanization involves various complex techniques, each designed to reduce non-human antibodies’ immunogenicity while maintaining or improving their therapeutic efficacy.

Cellmid Limited has signed a collaboration agreement with Antitope Ltd (Cambridge, UK) for the humanization of its lead therapeutic monoclonal antibody candidate. The collaboration is expected to ...

Intellect Neurosciences, Inc. and MRC Technology (MRCT) have announced that they have completed humanization of 82E1, a mouse monoclonal antibody to create a high-affinity stabilized IgG4 therapeutic ...

Antibody engineering enables the generation of novel and diverse antibody constructs. The development of therapeutic antibodies is highly dependent on antibody engineering, whether for the generation ...

Tzeng, S-F., et al. (2025) PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis.

In a step toward antibody humanization, Infinimmune has announced GLIMPSE-1, a protein language model trained solely on paired human antibody sequences with scalable applications in antibody ...

Leveraging these unique capabilities, the HYFT Proprietary Proteome Presence Assessment offers a more accurate and complete assessment of candidates' humanness and immunogenicity. This supports the ...

FREMONT, Calif. (CBS.MW) -- Protein Design Labs said on Tuesday that it has licensed two years of patent rights to certain antibodies to American Home Products Corp.